Merian Life Sciences ApS: Financial statements 2021
CVR: 40288589
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 394,441 and a net result of DKK 290,280 compared with DKK 334,417 the year before. That is a decrease of 13.8% compared with the year before. Equity in the 2021 report amounted to DKK 930,368. The solvency ratio was 87.9%.
- Gross Profit
- DKK 394,441
- Profit/Loss
- DKK 290,280
- Equity
- DKK 930,368
- Total Assets
- DKK 1,058,582
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 394K | 290K | 930K | 0 |
| 2020 | - | 457K | 334K | 619K | 0 |
| 2019 | - | 345K | 234K | 284K | 1 |
Official annual report
Find more companies like Merian Life Sciences ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Merian Life Sciences ApS has published its annual report for 2020. Gross profit came to DKK 457,443, and the net result was DKK 334,417.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.